Sofinnova News
Henrijette Richter appointed Managing Partner of Sofinnova Partners
Henrijette Richter appointed Managing Partner of Sofinnova Partners
Related Deal lead
Henrijette RichterHenrijette Richter appointed Managing Partner of Sofinnova Partners
Related News
Rezera announces phase 1 results for Trabzanoflast, which was generally well tolerated and demonstrated high central nervous system exposure (CNS)
Sofinnova Partners closes oversubscribed €82 million Sofinnova MD Start IV fund to create the next generation of medtech companies
Before the breakthrough: Sofinnova's decade-long bet on HighLife
NodThera changes name to Rezera Inc. and announces Ruvonoflast Phase 3 development program
Rezera announces Ruvonoflast met primary inflammation endpoint and demonstrated favorable safety profile in trial